Tuberculosis

At USAID, we focus our investments on strengthening national TB strategies and programs in 23 priority countries with high rates of TB, drug-resistant TB and HIV-associated TB.

The U.S. Agency for International Development (USAID) supports high-quality screening, diagnosis and treatment services for millions of people affected by TB and multidrug-resistant tuberculosis (MDR-TB). In Fiscal Year 2015, with investments of $242 million focused primarily in 23 countries with bilateral TB funds, the U.S. Government achieved the following results in collaboration with each country's programs:

• More than 3.7 million TB cases detected and diagnosed.
• More than 2.8 million people provided with TB treatment.
• More than 70,000 people with MDR-TB started on appropriate treatment.

USAID's FY 2015 investments contributed to an estimated 49 million lives saved from 2000-2015, including people co-infected with HIV and AIDS, leading to a 22 percent decline in TB mortality and a 21 percent decline in TB incidence globally since 2000.

What We Do

USAID works with partner governments to:

• Prevent TB transmission and renew efforts to find the missing TB cases
• Strengthen the capacity of national TB programs
• Build country capacity to use existing resources and to turn evidence into policy
• Expand the development of new TB diagnostics, drugs and vaccines